{
  "DOI": "10.1186/s40246-023-00497-1",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-023-00497-1",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003eKnowledge of the frequency of rare \u003cjats:italic\u003eSERPINA1\u003c/jats:italic\u003e mutations could help in the management of alpha1 antitrypsin deficiency (AATD). The present study aims to assess the frequencies of rare and null alleles and their respiratory and hepatic pathogenicity.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eMethods\u003c/jats:title\u003e\n                \u003cjats:p\u003eThis is a secondary analysis of a study that evaluated the viability of the Progenika diagnostic genotyping system in six different countries by analyzing 30,827 samples from cases of suspected AATD. Allele-specific genotyping was carried out with the Progenika A1AT Genotyping Test which analyses 14 mutations in buccal swabs or dried blood spots samples. \u003cjats:italic\u003eSERPINA1\u003c/jats:italic\u003e gene sequencing was performed for serum AAT-genotype discrepancies or by request of the clinician. Only cases with rare mutations were included in this analysis.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eResults\u003c/jats:title\u003e\n                \u003cjats:p\u003eThere were 818 cases (2.6%) carrying a rare allele, excluding newly identified mutations. All were heterozygous except for 20 that were homozygous. The most frequent alleles were the M-like alleles, PI*M\u003cjats:sub\u003emalton\u003c/jats:sub\u003e and PI*M\u003cjats:sub\u003eheerlen\u003c/jats:sub\u003e. Of the 14 mutations included in the Progenika panel, there were no cases detected of PI*S\u003cjats:sub\u003eiiyama\u003c/jats:sub\u003e, PI*Q0\u003cjats:sub\u003egranite falls\u003c/jats:sub\u003e and PI*Q0\u003cjats:sub\u003ewest\u003c/jats:sub\u003e. Other alleles not included in the 14-mutation panel and identified by gene sequencing included PI*M\u003cjats:sub\u003ewürzburg\u003c/jats:sub\u003e, PI*Z\u003cjats:sub\u003ebristol\u003c/jats:sub\u003e, and PI*Z\u003cjats:sub\u003ewrexham\u003c/jats:sub\u003e, and the null alleles PI*Q0\u003cjats:sub\u003eporto\u003c/jats:sub\u003e, PI*Q0\u003cjats:sub\u003emadrid\u003c/jats:sub\u003e, PI*Q0\u003cjats:sub\u003ebrescia\u003c/jats:sub\u003e, and PI*Q0\u003cjats:sub\u003ekayseri\u003c/jats:sub\u003e.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusions\u003c/jats:title\u003e\n                \u003cjats:p\u003eThe Progenika diagnostic network has allowed the identification of several rare alleles, some unexpected and not included in the initial diagnostic panel. This establishes a new perspective on the distribution of these alleles in different countries. These findings may help prioritize allele selection for routine testing and highlights the need for further research into their pathogenetic role.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "497"
  ],
  "article-number": "48",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "27 December 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "30 May 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "5 June 2023"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "This study reports the results of a diagnostic procedure that is approved for use in all the participating countries and, therefore, constitutes standard clinical practice. Consequently, since it is not an experimental procedure, approval by an ethics committee was not considered necessary. All patients included signed a written informed consent form."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "JLLC has received honoraria during the last 3 years for lecturing, scientific advice, participation in clinical studies or writing for publications for (alphabetical order): AstraZeneca, Bial, Boehringer, Chiesi, CSL Behring, Faes, Ferrer, Gebro, Grifols, GSK, Megalabs, Menarini, Novartis. MM has received speaker fees from AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, Menarini, Kamada, Takeda, Zambon, CSL Behring, Specialty Therapeutics, Janssen, Grifols and Novartis, consulting fees from AstraZeneca, Atriva Therapeutics, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, CSL Behring, Inhibrx, Ferrer, Menarini, Mereo Biopharma, Spin Therapeutics, ONO Pharma, Palobiofarma SL, Takeda, Novartis, Sanofi and Grifols and research grants from Grifols. LO works as geneticist at Progenika Biopharma, a Grifols Company. ED works in Scientific and Medical Affairs at Grifols."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Lopez-Campos",
      "given": "José Luis",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Rapun",
      "given": "Noelia",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Czischke",
      "given": "Karen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Jardim",
      "given": "José R.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Acquier",
      "given": "Mariano Fernandez",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Munive",
      "given": "Abraham Ali",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Günen",
      "given": "Hakan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Drobnic",
      "given": "Estrella",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Miravitlles",
      "given": "Marc",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Osaba",
      "given": "Lourdes",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        6,
        5
      ]
    ],
    "date-time": "2023-06-05T15:02:04Z",
    "timestamp": 1685977324000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        6,
        5
      ]
    ],
    "date-time": "2023-06-05T16:03:10Z",
    "timestamp": 1685980990000
  },
  "funder": [
    {
      "DOI": "10.13039/501100016387",
      "award": [
        "xxx",
        "xxx",
        "xxx"
      ],
      "doi-asserted-by": "crossref",
      "name": "Grifols"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        2,
        19
      ]
    ],
    "date-time": "2024-02-19T09:57:59Z",
    "timestamp": 1708336679824
  },
  "is-referenced-by-count": 1,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2023,
        6,
        5
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2023,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            6,
            5
          ]
        ],
        "date-time": "2023-06-05T00:00:00Z",
        "timestamp": 1685923200000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            6,
            5
          ]
        ],
        "date-time": "2023-06-05T00:00:00Z",
        "timestamp": 1685923200000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00497-1.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-023-00497-1/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00497-1.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2023,
        6,
        5
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        6,
        5
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1186/s12931-022-02074-x",
      "author": "JL Lopez-Campos",
      "doi-asserted-by": "publisher",
      "first-page": "152",
      "issue": "1",
      "journal-title": "Respir Res",
      "key": "497_CR1",
      "unstructured": "Lopez-Campos JL, Osaba L, Czischke K, Jardim JR, Fernandez Acquier M, Ali A, Günen H, Rapun N, Drobnic E, Miravitlles M. Feasibility of a genotyping system for the diagnosis of alpha1 antitrypsin deficiency: a multinational cross-sectional analysis. Respir Res. 2022;23(1):152.",
      "volume": "23",
      "year": "2022"
    },
    {
      "DOI": "10.2147/TACG.S257511",
      "author": "S Seixas",
      "doi-asserted-by": "publisher",
      "first-page": "173",
      "journal-title": "Appl Clin Genet",
      "key": "497_CR2",
      "unstructured": "Seixas S, Marques PI. Known mutations at the cause of alpha-1 antitrypsin deficiency an updated overview of SERPINA1 variation spectrum. Appl Clin Genet. 2021;14:173–94.",
      "volume": "14",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.arbr.2020.04.010",
      "author": "JL Lopez-Campos",
      "doi-asserted-by": "publisher",
      "first-page": "42",
      "issue": "1",
      "journal-title": "Arch Bronconeumol (Engl Ed)",
      "key": "497_CR3",
      "unstructured": "Lopez-Campos JL, Casas-Maldonado F, Torres-Duran M, Medina-Gonzalvez A, Rodriguez-Fidalgo ML, Carrascosa I, Calle M, Osaba L, Rapun N, Drobnic E, et al. Results of a diagnostic procedure based on multiplex technology on dried blood spots and buccal swabs for subjects with suspected alpha1 antitrypsin deficiency. Arch Bronconeumol (Engl Ed). 2021;57(1):42–50.",
      "volume": "57",
      "year": "2021"
    },
    {
      "DOI": "10.1165/rcmb.2017-0179OC",
      "author": "N Matamala",
      "doi-asserted-by": "publisher",
      "first-page": "706",
      "issue": "6",
      "journal-title": "Am J Respir Cell Mol Biol",
      "key": "497_CR4",
      "unstructured": "Matamala N, Lara B, Gomez-Mariano G, Martinez S, Retana D, Fernandez T, Silvestre RA, Belmonte I, Rodriguez-Frias F, Vilar M, et al. Characterization of novel missense variants of SERPINA1 gene causing alpha-1 antitrypsin deficiency. Am J Respir Cell Mol Biol. 2018;58(6):706–16.",
      "volume": "58",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.arbres.2022.05.012",
      "author": "PJM Hernández",
      "doi-asserted-by": "publisher",
      "first-page": "731",
      "issue": "10",
      "journal-title": "Archivos de bronconeumologia",
      "key": "497_CR5",
      "unstructured": "Hernández PJM, López CCV. Alpha-1 antitrypsin deficiency severe and no severe. Is it benefit or risk? Archivos de bronconeumologia. 2022;58(10):731–2.",
      "volume": "58",
      "year": "2022"
    },
    {
      "DOI": "10.1016/j.arbres.2014.05.008",
      "author": "F Casas",
      "doi-asserted-by": "publisher",
      "first-page": "185",
      "issue": "4",
      "journal-title": "Arch Bronconeumol",
      "key": "497_CR6",
      "unstructured": "Casas F, Blanco I, Martinez MT, Bustamante A, Miravitlles M, Cadenas S, Hernandez JM, Lazaro L, Rodriguez E, Rodriguez-Frias F, et al. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update. Arch Bronconeumol. 2015;51(4):185–92.",
      "volume": "51",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.arbres.2020.03.006",
      "author": "N Matamala",
      "doi-asserted-by": "publisher",
      "first-page": "457",
      "issue": "7",
      "journal-title": "Arch Bronconeumol",
      "key": "497_CR7",
      "unstructured": "Matamala N, Lara B, Gómez-Mariano G, Martínez S, Vázquez-Domínguez I, Otero-Sobrino Á, Muñoz-Callejas A, Sánchez E, Esquinas C, Bustamante A, et al. miR-320c regulates SERPINA1 expression and is induced in patients with pulmonary disease. Arch Bronconeumol. 2021;57(7):457–63.",
      "volume": "57",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.arbres.2022.07.002",
      "author": "DG Parr",
      "doi-asserted-by": "publisher",
      "first-page": "840",
      "issue": "12",
      "journal-title": "Arch Bronconeumol",
      "key": "497_CR8",
      "unstructured": "Parr DG, Chorostowska-Wynimko J, Corsico A, Esquinas C, McElvaney GN, Sark AD, Sucena M, Tanash H, Turner AM, Miravitlles M. Impact of COVID-19 in patients with severe alpha-1 antitrypsin deficiency: the IMCA1 study of the EARCO clinical research collaboration. Arch Bronconeumol. 2022;58(12):840–2.",
      "volume": "58",
      "year": "2022"
    },
    {
      "DOI": "10.1016/j.arbres.2020.10.009",
      "author": "M Strassmair",
      "doi-asserted-by": "publisher",
      "first-page": "97",
      "journal-title": "Arch Bronconeumol",
      "key": "497_CR9",
      "unstructured": "Strassmair M, Stangl M. Alpha-1 antitrypsin deficiency and COVID-19 infection. Arch Bronconeumol. 2021;57:97.",
      "volume": "57",
      "year": "2021"
    },
    {
      "DOI": "10.1002/jcla.23279",
      "author": "S Ottaviani",
      "doi-asserted-by": "publisher",
      "first-page": "e23279",
      "issue": "7",
      "journal-title": "J Clin Lab Anal",
      "key": "497_CR10",
      "unstructured": "Ottaviani S, Barzon V, Buxens A, Gorrini M, Larruskain A, El Hamss R, Balderacchi AM, Corsico AG, Ferrarotti I. Molecular diagnosis of alpha1-antitrypsin deficiency: a new method based on Luminex technology. J Clin Lab Anal. 2020;34(7):e23279.",
      "volume": "34",
      "year": "2020"
    },
    {
      "DOI": "10.2147/COPD.S224221",
      "author": "M Veith",
      "doi-asserted-by": "publisher",
      "first-page": "2535",
      "journal-title": "Int J Chron Obstruct Pulmon Dis",
      "key": "497_CR11",
      "unstructured": "Veith M, Klemmer A, Anton I, El Hamss R, Rapun N, Janciauskiene S, Kotke V, Herr C, Bals R, Vogelmeier CF, et al. Diagnosing alpha-1-antitrypsin deficiency using a PCR/Luminescence-based technology. Int J Chron Obstruct Pulmon Dis. 2019;14:2535–42.",
      "volume": "14",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.rmed.2007.02.024",
      "author": "R Bals",
      "doi-asserted-by": "publisher",
      "first-page": "1708",
      "issue": "8",
      "journal-title": "Respir Med",
      "key": "497_CR12",
      "unstructured": "Bals R, Koczulla R, Kotke V, Andress J, Blackert K, Vogelmeier C. Identification of individuals with alpha-1-antitrypsin deficiency by a targeted screening program. Respir Med. 2007;101(8):1708–14.",
      "volume": "101",
      "year": "2007"
    },
    {
      "DOI": "10.1136/jmg.2004.023903",
      "author": "I Ferrarotti",
      "doi-asserted-by": "publisher",
      "first-page": "282",
      "issue": "3",
      "journal-title": "J Med Genet",
      "key": "497_CR13",
      "unstructured": "Ferrarotti I, Baccheschi J, Zorzetto M, Tinelli C, Corda L, Balbi B, Campo I, Pozzi E, Faa G, Coni P, et al. Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency. J Med Genet. 2005;42(3):282–7.",
      "volume": "42",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.rmed.2007.10.015",
      "author": "I Ferrarotti",
      "doi-asserted-by": "publisher",
      "first-page": "354",
      "issue": "3",
      "journal-title": "Respir Med",
      "key": "497_CR14",
      "unstructured": "Ferrarotti I, Gorrini M, Scabini R, Ottaviani S, Mazzola P, Campo I, Zorzetto M, Luisetti M. Secondary outputs of alpha1-antitrypsin deficiency targeted detection programme. Respir Med. 2008;102(3):354–8.",
      "volume": "102",
      "year": "2008"
    },
    {
      "DOI": "10.1186/1750-1172-4-12",
      "author": "S Denden",
      "doi-asserted-by": "publisher",
      "first-page": "12",
      "journal-title": "Orphanet J Rare Dis",
      "key": "497_CR15",
      "unstructured": "Denden S, Zorzetto M, Amri F, Knani J, Ottaviani S, Scabini R, Gorrini M, Ferrarotti I, Campo I, Chibani JB, et al. Screening for alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report. Orphanet J Rare Dis. 2009;4:12.",
      "volume": "4",
      "year": "2009"
    },
    {
      "DOI": "10.1373/clinchem.2007.102798",
      "author": "M Zorzetto",
      "doi-asserted-by": "publisher",
      "first-page": "1331",
      "issue": "8",
      "journal-title": "Clin Chem",
      "key": "497_CR16",
      "unstructured": "Zorzetto M, Russi E, Senn O, Imboden M, Ferrarotti I, Tinelli C, Campo I, Ottaviani S, Scabini R, von Eckardstein A, et al. SERPINA1 gene variants in individuals from the general population with reduced alpha1-antitrypsin concentrations. Clin Chem. 2008;54(8):1331–8.",
      "volume": "54",
      "year": "2008"
    },
    {
      "DOI": "10.1177/1753465811434320",
      "author": "F Rodriguez-Frias",
      "doi-asserted-by": "publisher",
      "first-page": "79",
      "issue": "2",
      "journal-title": "Ther Adv Respir Dis",
      "key": "497_CR17",
      "unstructured": "Rodriguez-Frias F, Miravitlles M, Vidal R, Camos S, Jardi R. Rare alpha-1-antitrypsin variants: are they really so rare? Ther Adv Respir Dis. 2012;6(2):79–85.",
      "volume": "6",
      "year": "2012"
    },
    {
      "DOI": "10.1007/5584_2016_213",
      "author": "K Duk",
      "doi-asserted-by": "publisher",
      "first-page": "47",
      "journal-title": "Adv Exp Med Biol",
      "key": "497_CR18",
      "unstructured": "Duk K, Zdral A, Szumna B, Roży A, Chorostowska-Wynimko J. Frequency of rare alpha-1 antitrypsin variants in polish patients with chronic respiratory disorders. Adv Exp Med Biol. 2016;910:47–53.",
      "volume": "910",
      "year": "2016"
    },
    {
      "DOI": "10.55730/1300-0144.5486",
      "author": "M Çörtük",
      "doi-asserted-by": "publisher",
      "first-page": "1478",
      "issue": "5",
      "journal-title": "Turkish J Med Sci",
      "key": "497_CR19",
      "unstructured": "Çörtük M, Demirkol B, Arslan MA, İlhan U, Kalkan YE, Turan D, Gül Ş, Çinarka H, Baydili KN, Çetinkaya E. Frequency of alpha-1 antitrypsin deficiency and unexpected results in COPD patients in Turkey; rare variants are common. Turkish J Med Sci. 2022;52(5):1478–85.",
      "volume": "52",
      "year": "2022"
    },
    {
      "author": "GS Wiesemann",
      "first-page": "689",
      "journal-title": "Chronic Obstruct Pulm Dis",
      "key": "497_CR20",
      "unstructured": "Wiesemann GS, Oshins RA, Flagg TO, Brantly ML. Novel SERPINA1 alleles identified through a large alpha-1 antitrypsin deficiency screening program and review of known variants. Chronic Obstruct Pulm Dis. 2022;5:689.",
      "volume": "5",
      "year": "2022"
    },
    {
      "author": "R Jardi",
      "first-page": "213",
      "issue": "3",
      "journal-title": "Hum Mutat",
      "key": "497_CR21",
      "unstructured": "Jardi R, Rodriguez F, Miravitlles M, Vidal R, Cotrina M, Quer J, Pascual C, Weidinger S. Identification and molecular characterization of the new alpha-1-antitrypsin deficient allele PI Y barcelona (Asp256--\u003eVal and Pro391--\u003eHis). Mutations in brief no. 174. Hum Mutat. 1998;12(3):213.",
      "volume": "12",
      "year": "1998"
    },
    {
      "DOI": "10.1111/j.1699-0463.1967.tb01310.x",
      "author": "MK Fagerhol",
      "doi-asserted-by": "publisher",
      "first-page": "421",
      "issue": "3",
      "journal-title": "Acta Pathol Microbiol Scand",
      "key": "497_CR22",
      "unstructured": "Fagerhol MK. Serum Pi types in Norwegians. Acta Pathol Microbiol Scand. 1967;70(3):421–8.",
      "volume": "70",
      "year": "1967"
    },
    {
      "DOI": "10.1172/JCI4874",
      "author": "R Mahadeva",
      "doi-asserted-by": "publisher",
      "first-page": "999",
      "issue": "7",
      "journal-title": "J Clin Investig",
      "key": "497_CR23",
      "unstructured": "Mahadeva R, Chang WS, Dafforn TR, Oakley DJ, Foreman RC, Calvin J, Wight DG, Lomas DA. Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis. J Clin Investig. 1999;103(7):999–1006.",
      "volume": "103",
      "year": "1999"
    },
    {
      "DOI": "10.1378/chest.12-0564",
      "author": "JA Bornhorst",
      "doi-asserted-by": "publisher",
      "first-page": "1000",
      "issue": "4",
      "journal-title": "Chest",
      "key": "497_CR24",
      "unstructured": "Bornhorst JA, Greene DN, Ashwood ER, Grenache DG. α1-Antitrypsin phenotypes and associated serum protein concentrations in a large clinical population. Chest. 2013;143(4):1000–8.",
      "volume": "143",
      "year": "2013"
    },
    {
      "author": "P Arnaud",
      "first-page": "177",
      "issue": "2",
      "journal-title": "J Lab Clin Med",
      "key": "497_CR25",
      "unstructured": "Arnaud P, Chapuis-Cellier C, Vittoz P, Fudenberg HH. Genetic polymorphism of serum alpha-1-protease inhibitor (alpha-1-antitrypsin): Pi i, a deficient allele of the Pi system. J Lab Clin Med. 1978;92(2):177–84.",
      "volume": "92",
      "year": "1978"
    },
    {
      "DOI": "10.1007/BF02591409",
      "author": "M Seri",
      "doi-asserted-by": "publisher",
      "first-page": "119",
      "issue": "2",
      "journal-title": "Int J Clin Lab Res",
      "key": "497_CR26",
      "unstructured": "Seri M, Magi B, Cellesi C, Olia PM, Renieri A, De Marchi M. Molecular characterization of the P and I variants of alpha 1-antitrypsin. Int J Clin Lab Res. 1992;22(2):119–21.",
      "volume": "22",
      "year": "1992"
    },
    {
      "author": "H Okayama",
      "first-page": "1154",
      "issue": "6",
      "journal-title": "Am J Hum Genet",
      "key": "497_CR27",
      "unstructured": "Okayama H, Brantly M, Holmes M, Crystal RG. Characterization of the molecular basis of the alpha 1-antitrypsin F allele. Am J Hum Genet. 1991;48(6):1154–8.",
      "volume": "48",
      "year": "1991"
    },
    {
      "DOI": "10.1309/AJCPMEEJK32ACYFP",
      "author": "LJ Donato",
      "doi-asserted-by": "publisher",
      "first-page": "398",
      "issue": "3",
      "journal-title": "Am J Clin Pathol",
      "key": "497_CR28",
      "unstructured": "Donato LJ, Jenkins SM, Smith C, Katzmann JA, Snyder MR. Reference and interpretive ranges for α(1)-antitrypsin quantitation by phenotype in adult and pediatric populations. Am J Clin Pathol. 2012;138(3):398–405.",
      "volume": "138",
      "year": "2012"
    },
    {
      "DOI": "10.1080/00313029600169074",
      "author": "L Cook",
      "doi-asserted-by": "publisher",
      "first-page": "242",
      "issue": "3",
      "journal-title": "Pathology",
      "key": "497_CR29",
      "unstructured": "Cook L, Burdon JG, Brenton S, Knight KR, Janus ED. Kinetic characterisation of alpha-1-antitrypsin F as an inhibitor of human neutrophil elastase. Pathology. 1996;28(3):242–7.",
      "volume": "28",
      "year": "1996"
    },
    {
      "DOI": "10.1186/1471-2466-14-132",
      "author": "NJ Sinden",
      "doi-asserted-by": "publisher",
      "first-page": "132",
      "journal-title": "BMC Pulm Med",
      "key": "497_CR30",
      "unstructured": "Sinden NJ, Koura F, Stockley RA. The significance of the F variant of alpha-1-antitrypsin and unique case report of a PiFF homozygote. BMC Pulm Med. 2014;14:132.",
      "volume": "14",
      "year": "2014"
    },
    {
      "key": "497_CR31",
      "unstructured": "Cox DW. A new deficieny allele of alpha1-antitrypsin: Pi Mmalton. In: Protides of the biological fluids Proceedings of the twenty-third colloquium. Brugge: Pergamon Press, Ltd.; 1975. p. 375–378."
    },
    {
      "author": "E Matsunaga",
      "first-page": "602",
      "issue": "3",
      "journal-title": "Am J Hum Genet",
      "key": "497_CR32",
      "unstructured": "Matsunaga E, Shiokawa S, Nakamura H, Maruyama T, Tsuda K, Fukumaki Y. Molecular analysis of the gene of the alpha 1-antitrypsin deficiency variant, Mnichinan. Am J Hum Genet. 1990;46(3):602–12.",
      "volume": "46",
      "year": "1990"
    },
    {
      "author": "JP Faber",
      "first-page": "1113",
      "issue": "6",
      "journal-title": "Am J Hum Genet",
      "key": "497_CR33",
      "unstructured": "Faber JP, Poller W, Weidinger S, Kirchgesser M, Schwaab R, Bidlingmaier F, Olek K. Identification and DNA sequence analysis of 15 new alpha 1-antitrypsin variants, including two PI*Q0 alleles and one deficient PI*M allele. Am J Hum Genet. 1994;55(6):1113–21.",
      "volume": "55",
      "year": "1994"
    },
    {
      "DOI": "10.1016/j.rmed.2016.05.002",
      "author": "D Silva",
      "doi-asserted-by": "publisher",
      "first-page": "8",
      "journal-title": "Respir Med",
      "key": "497_CR34",
      "unstructured": "Silva D, Oliveira MJ, Guimarães M, Lima R, Gomes S, Seixas S. Alpha-1-antitrypsin (SERPINA1) mutation spectrum: three novel variants and haplotype characterization of rare deficiency alleles identified in Portugal. Respir Med. 2016;116:8–18.",
      "volume": "116",
      "year": "2016"
    },
    {
      "author": "GJM Figueira",
      "first-page": "708",
      "journal-title": "Pulmonology",
      "key": "497_CR35",
      "unstructured": "Figueira GJM, Martínez BF, Díaz PD, Martín MMD, García-Talavera I, Pitti PR. Clinical manifestations of the Mmalton alpha-1 antitrypsin deficiency variant. Pulmonology. 2017;5:708.",
      "volume": "5",
      "year": "2017"
    },
    {
      "DOI": "10.1038/sj.ejhg.5200304",
      "author": "W Poller",
      "doi-asserted-by": "publisher",
      "first-page": "321",
      "issue": "3",
      "journal-title": "Eur J Hum Genet",
      "key": "497_CR36",
      "unstructured": "Poller W, Merklein F, Schneider-Rasp S, Haack A, Fechner H, Wang H, Anagnostopoulos I, Weidinger S. Molecular characterisation of the defective alpha 1-antitrypsin alleles PI Mwurzburg (Pro369Ser), Mheerlen (Pro369Leu), and Q0lisbon (Thr68Ile). Eur J Hum Genet. 1999;7(3):321–31.",
      "volume": "7",
      "year": "1999"
    },
    {
      "DOI": "10.1159/000022935",
      "author": "R Jardi",
      "doi-asserted-by": "publisher",
      "first-page": "320",
      "issue": "5",
      "journal-title": "Hum Hered",
      "key": "497_CR37",
      "unstructured": "Jardi R, Rodriguez-Frias F, Lopez-Talavera JC, Miravitlles M, Cotrina M, Costa X, Pascual C, Vidal R. Characterization of the new alpha-1-antitrypsin-deficient PI M-type allele, PI M(vall d’hebron) (Pro(369)–\u003eSer). Hum Hered. 2000;50(5):320–1.",
      "volume": "50",
      "year": "2000"
    },
    {
      "DOI": "10.1007/BF00293055",
      "author": "JA Kramps",
      "doi-asserted-by": "publisher",
      "first-page": "104",
      "issue": "2",
      "journal-title": "Hum Genet",
      "key": "497_CR38",
      "unstructured": "Kramps JA, Brouwers JW, Maesen F, Dijkman JH. PiMheerlen, alpha PiM allele resulting in very low alpha 1-antitrypsin serum levels. Hum Genet. 1981;59(2):104–7.",
      "volume": "59",
      "year": "1981"
    },
    {
      "DOI": "10.1007/BF00279001",
      "author": "MH Hofker",
      "doi-asserted-by": "publisher",
      "first-page": "264",
      "issue": "3",
      "journal-title": "Hum Genet",
      "key": "497_CR39",
      "unstructured": "Hofker MH, Nukiwa T, van Paassen HM, Nelen M, Kramps JA, Klasen EC, Frants RR, Crystal RG. A Pro––Leu substitution in codon 369 of the alpha-1-antitrypsin deficiency variant PI MHeerlen. Hum Genet. 1989;81(3):264–8.",
      "volume": "81",
      "year": "1989"
    },
    {
      "DOI": "10.1016/S0021-9258(19)37620-3",
      "author": "H Takahashi",
      "doi-asserted-by": "publisher",
      "first-page": "15528",
      "issue": "30",
      "journal-title": "J Biol Chem",
      "key": "497_CR40",
      "unstructured": "Takahashi H, Nukiwa T, Satoh K, Ogushi F, Brantly M, Fells G, Stier L, Courtney M, Crystal RG. Characterization of the gene and protein of the alpha 1-antitrypsin “deficiency” allele Mprocida. J Biol Chem. 1988;263(30):15528–34.",
      "volume": "263",
      "year": "1988"
    },
    {
      "DOI": "10.1111/j.1423-0410.1968.tb04081.x",
      "author": "MK Fagerhol",
      "doi-asserted-by": "publisher",
      "first-page": "396",
      "issue": "5",
      "journal-title": "Vox Sang",
      "key": "497_CR41",
      "unstructured": "Fagerhol MK, Hauge HE. The Pi phenotype MP. Discovery of a ninth allele belonging to the system of inherited variants of serum alpha 1 antitrypsin. Vox Sang. 1968;15(5):396–400.",
      "volume": "15",
      "year": "1968"
    },
    {
      "DOI": "10.1164/ajrccm/142.5.1185",
      "author": "MD Holmes",
      "doi-asserted-by": "publisher",
      "first-page": "1185",
      "issue": "5",
      "journal-title": "Am Rev Respir Dis",
      "key": "497_CR42",
      "unstructured": "Holmes MD, Brantly ML, Crystal RG. Molecular analysis of the heterogeneity among the P-family of alpha-1-antitrypsin alleles. Am Rev Respir Dis. 1990;142(5):1185–92.",
      "volume": "142",
      "year": "1990"
    },
    {
      "DOI": "10.1002/humu.1380020311",
      "author": "J Hildesheim",
      "doi-asserted-by": "publisher",
      "first-page": "221",
      "issue": "3",
      "journal-title": "Hum Mutat",
      "key": "497_CR43",
      "unstructured": "Hildesheim J, Kinsley G, Bissell M, Pierce J, Brantly M. Genetic diversity from a limited repertoire of mutations on different common allelic backgrounds: alpha 1-antitrypsin deficiency variant Pduarte. Hum Mutat. 1993;2(3):221–8.",
      "volume": "2",
      "year": "1993"
    },
    {
      "DOI": "10.1136/jcp.2006.042762",
      "author": "JA Bornhorst",
      "doi-asserted-by": "publisher",
      "first-page": "1124",
      "issue": "10",
      "journal-title": "J Clin Pathol",
      "key": "497_CR44",
      "unstructured": "Bornhorst JA, Calderon FR, Procter M, Tang W, Ashwood ER, Mao R. Genotypes and serum concentrations of human alpha-1-antitrypsin “P” protein variants in a clinical population. J Clin Pathol. 2007;60(10):1124–8.",
      "volume": "60",
      "year": "2007"
    },
    {
      "DOI": "10.1111/j.1445-5994.1995.tb02855.x",
      "author": "L Cook",
      "doi-asserted-by": "publisher",
      "first-page": "695",
      "issue": "6",
      "journal-title": "Aust N Z J Med",
      "key": "497_CR45",
      "unstructured": "Cook L, Burdon J, Brenton S, Janus ED, Knight K. Alpha-1-antitrypsin PLowell: a normally functioning variant present in low concentration. Aust N Z J Med. 1995;25(6):695–7.",
      "volume": "25",
      "year": "1995"
    },
    {
      "DOI": "10.1371/journal.pone.0038405",
      "author": "AM Fra",
      "doi-asserted-by": "publisher",
      "first-page": "e38405",
      "issue": "6",
      "journal-title": "PLoS ONE",
      "key": "497_CR46",
      "unstructured": "Fra AM, Gooptu B, Ferrarotti I, Miranda E, Scabini R, Ronzoni R, Benini F, Corda L, Medicina D, Luisetti M, et al. Three new alpha1-antitrypsin deficiency variants help to define a C-terminal region regulating conformational change and polymerization. PLoS ONE. 2012;7(6):e38405.",
      "volume": "7",
      "year": "2012"
    },
    {
      "DOI": "10.1378/chest.124.1.404",
      "author": "M Miravitlles",
      "doi-asserted-by": "publisher",
      "first-page": "404",
      "issue": "1",
      "journal-title": "Chest",
      "key": "497_CR47",
      "unstructured": "Miravitlles M, Vilà S, Jardí R, de la Roza C, Rodríguez-Frías F, Vidal R. Emphysema due to alpha-antitrypsin deficiency: familial study of the YBARCELONA variant. Chest. 2003;124(1):404–6.",
      "volume": "124",
      "year": "2003"
    },
    {
      "author": "JU Lovegrove",
      "first-page": "385",
      "issue": "Pt 5",
      "journal-title": "Ann Hum Genet",
      "key": "497_CR48",
      "unstructured": "Lovegrove JU, Jeremiah S, Gillett GT, Temple IK, Povey S, Whitehouse DB. A new alpha 1-antitrypsin mutation, Thr-Met 85, (PI Zbristol) associated with novel electrophoretic properties. Ann Hum Genet. 1997;61(Pt 5):385–91.",
      "volume": "61",
      "year": "1997"
    },
    {
      "DOI": "10.1177/0004563213484303",
      "author": "KJ Bates",
      "doi-asserted-by": "publisher",
      "first-page": "618",
      "issue": "Pt 6",
      "journal-title": "Ann Clin Biochem",
      "key": "497_CR49",
      "unstructured": "Bates KJ, Puxley M, Hill M, Kalsheker N, Barlow A, Clark BE, Sherwood RA. A patient with the rare alpha-1-antitrypsin variant (Z)bristol in compound heterozygosity with the Z mutation. Ann Clin Biochem. 2013;50(Pt 6):618–21.",
      "volume": "50",
      "year": "2013"
    },
    {
      "DOI": "10.1177/0004563212473443",
      "author": "TH Hoàng",
      "doi-asserted-by": "publisher",
      "first-page": "339",
      "issue": "Pt 4",
      "journal-title": "Ann Clin Biochem",
      "key": "497_CR50",
      "unstructured": "Hoàng TH, Phạm TN, Nguyễn GK, Lê QH. A rare variant of α 1 antitrypsin mutations detected in Vietnamese children with liver disease. Ann Clin Biochem. 2013;50(Pt 4):339–44.",
      "volume": "50",
      "year": "2013"
    },
    {
      "DOI": "10.1007/BF00194233",
      "author": "A Graham",
      "doi-asserted-by": "publisher",
      "first-page": "537",
      "issue": "5",
      "journal-title": "Hum Genet",
      "key": "497_CR51",
      "unstructured": "Graham A, Kalsheker NA, Bamforth FJ, Newton CR, Markham AF. Molecular characterisation of two alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) Null(Newport) (Gly115-Ser) and (Pi) Z Wrexham (Ser-19-Leu). Hum Genet. 1990;85(5):537–40.",
      "volume": "85",
      "year": "1990"
    },
    {
      "DOI": "10.1056/NEJM198603203141207",
      "author": "RI Garver Jr",
      "doi-asserted-by": "publisher",
      "first-page": "762",
      "issue": "12",
      "journal-title": "N Engl J Med",
      "key": "497_CR52",
      "unstructured": "Garver RI Jr, Mornex JF, Nukiwa T, Brantly M, Courtney M, LeCocq JP, Crystal RG. Alpha 1-antitrypsin deficiency and emphysema caused by homozygous inheritance of non-expressing alpha 1-antitrypsin genes. N Engl J Med. 1986;314(12):762–6.",
      "volume": "314",
      "year": "1986"
    },
    {
      "DOI": "10.1016/S0021-9258(18)45309-4",
      "author": "T Nukiwa",
      "doi-asserted-by": "publisher",
      "first-page": "11999",
      "issue": "25",
      "journal-title": "J Biol Chem",
      "key": "497_CR53",
      "unstructured": "Nukiwa T, Takahashi H, Brantly M, Courtney M, Crystal RG. Alpha 1-antitrypsin nullGranite Falls, a nonexpressing alpha 1-antitrypsin gene associated with a frameshift to stop mutation in a coding exon. J Biol Chem. 1987;262(25):11999–2004.",
      "volume": "262",
      "year": "1987"
    },
    {
      "DOI": "10.1186/s12931-014-0125-y",
      "author": "B Lara",
      "doi-asserted-by": "publisher",
      "first-page": "125",
      "issue": "1",
      "journal-title": "Respir Res",
      "key": "497_CR54",
      "unstructured": "Lara B, Martínez MT, Blanco I, Hernández-Moro C, Velasco EA, Ferrarotti I, Rodriguez-Frias F, Perez L, Vazquez I, Alonso J, et al. Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid. Respir Res. 2014;15(1):125.",
      "volume": "15",
      "year": "2014"
    },
    {
      "author": "DW Cox",
      "first-page": "844",
      "issue": "6",
      "journal-title": "Am J Hum Genet",
      "key": "497_CR55",
      "unstructured": "Cox DW, Billingsley GD. Rare deficiency types of alpha 1-antitrypsin: electrophoretic variation and DNA haplotypes. Am J Hum Genet. 1989;44(6):844–54.",
      "volume": "44",
      "year": "1989"
    },
    {
      "DOI": "10.1034/j.1399-0004.2002.620212.x",
      "author": "S Seixas",
      "doi-asserted-by": "publisher",
      "first-page": "175",
      "issue": "2",
      "journal-title": "Clin Genet",
      "key": "497_CR56",
      "unstructured": "Seixas S, Mendonça C, Costa F, Rocha J. Alpha1-antitrypsin null alleles: evidence for the recurrence of the L353fsX376 mutation and a novel G–\u003eA transition in position + 1 of intron IC affecting normal mRNA splicing. Clin Genet. 2002;62(2):175–80.",
      "volume": "62",
      "year": "2002"
    },
    {
      "DOI": "10.1093/hmg/2.7.1001",
      "author": "VE Laubach",
      "doi-asserted-by": "publisher",
      "first-page": "1001",
      "issue": "7",
      "journal-title": "Hum Mol Genet",
      "key": "497_CR57",
      "unstructured": "Laubach VE, Ryan WJ, Brantly M. Characterization of a human alpha 1-antitrypsin null allele involving aberrant mRNA splicing. Hum Mol Genet. 1993;2(7):1001–5.",
      "volume": "2",
      "year": "1993"
    },
    {
      "DOI": "10.1165/ajrcmb.16.3.9070606",
      "author": "M Brantly",
      "doi-asserted-by": "publisher",
      "first-page": "225",
      "issue": "3",
      "journal-title": "Am J Respir Cell Mol Biol",
      "key": "497_CR58",
      "unstructured": "Brantly M, Lee JH, Hildesheim J, Uhm CS, Prakash UB, Staats BA, Crystal RG, Hildeshiem J. Alpha1-antitrypsin gene mutation hot spot associated with the formation of a retained and degraded null variant [corrected; erratum to be published]. Am J Respir Cell Mol Biol. 1997;16(3):225–31.",
      "volume": "16",
      "year": "1997"
    },
    {
      "DOI": "10.1016/S0021-9258(18)98945-3",
      "author": "K Seyama",
      "doi-asserted-by": "publisher",
      "first-page": "12627",
      "issue": "19",
      "journal-title": "J Biol Chem",
      "key": "497_CR59",
      "unstructured": "Seyama K, Nukiwa T, Takabe K, Takahashi H, Miyake K, Kira S. Siiyama (serine 53 (TCC) to phenylalanine 53 (TTC)). A new alpha 1-antitrypsin-deficient variant with mutation on a predicted conserved residue of the serpin backbone. J Biol Chem. 1991;266(19):12627–32.",
      "volume": "266",
      "year": "1991"
    }
  ],
  "reference-count": 59,
  "references-count": 59,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-023-00497-1"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Distribution of alpha1 antitrypsin rare alleles in six countries: Results from the Progenika diagnostic network"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "17"
}